KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other Non-Current Assets: 2009-2025

Historic Other Non-Current Assets for Neogenomics (NEO) over the last 15 years, with Sep 2025 value amounting to $8.2 million.

  • Neogenomics' Other Non-Current Assets rose 46.70% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year increase of 46.70%. This contributed to the annual value of $5.9 million for FY2024, which is 24.12% up from last year.
  • Neogenomics' Other Non-Current Assets amounted to $8.2 million in Q3 2025, which was up 14.90% from $7.1 million recorded in Q2 2025.
  • Neogenomics' 5-year Other Non-Current Assets high stood at $11.1 million for Q1 2021, and its period low was $4.1 million during Q2 2024.
  • In the last 3 years, Neogenomics' Other Non-Current Assets had a median value of $5.4 million in 2023 and averaged $5.6 million.
  • In the last 5 years, Neogenomics' Other Non-Current Assets plummeted by 78.70% in 2021 and then spiked by 74.90% in 2025.
  • Quarterly analysis of 5 years shows Neogenomics' Other Non-Current Assets stood at $7.2 million in 2021, then dropped by 28.72% to $5.1 million in 2022, then decreased by 7.18% to $4.7 million in 2023, then climbed by 24.12% to $5.9 million in 2024, then soared by 46.70% to $8.2 million in 2025.
  • Its Other Non-Current Assets was $8.2 million in Q3 2025, compared to $7.1 million in Q2 2025 and $6.0 million in Q1 2025.